Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cipolla

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Journal of Colloid and Interface Science|August 10, 2019
Controlling the size and shape of liposomal ciprofloxacin nanocrystals by varying the lipid bilayer composition and drug to lipid ratioTang Li, Andrew J Clulow, Cameron J Nowell, et al.
Pharmaceutics|March 29, 2023
Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation PowderHelena Gauani, Thomas Baker, Zhili Li, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 8, 2010
Pulmonary formulations: what remains to be done?Jeffry G Weers, John Bell, Hak-Kim Chan, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 16, 2013
In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisationHui Xin Ong, Faiza Benaouda, Daniela Traini, et al.
Analytical Chemistry|June 20, 2020
Nanoscale Probing of Liposome Encapsulating Drug Nanocrystal Using Atomic Force Microscopy-Infrared SpectroscopyDipesh Khanal, Isra Khatib, Juanfang Ruan, et al.
Pharmaceutical Research|February 9, 2018
Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm InfectionChing-Yee Loo, Wing-Hin Lee, Gianluca Lauretani, et al.
The European Respiratory Journal|June 20, 2020
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studiesJames D Chalmers, David Cipolla, Bruce Thompson, et al.
Thorax|May 18, 2013
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trialDavid J Serisier, Diana Bilton, Anthony De Soyza, et al.
Pulmonary Pharmacology & Therapeutics|December 21, 2020
Treprostinil palmitil, an inhaled long-acting pulmonary vasodilator, does not show tachyphylaxis with daily dosing in ratsRichard W Chapman, Zhili Li, Donald Chun, et al.
European Journal of Pharmacology|September 11, 2021
Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertensionMichel R Corboz, Adam J Plaunt, Vladimir Malinin, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Journal of Colloid and Interface Science|August 10, 2019
Controlling the size and shape of liposomal ciprofloxacin nanocrystals by varying the lipid bilayer composition and drug to lipid ratioTang Li, Andrew J Clulow, Cameron J Nowell, et al.
Pharmaceutics|March 29, 2023
Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation PowderHelena Gauani, Thomas Baker, Zhili Li, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 8, 2010
Pulmonary formulations: what remains to be done?Jeffry G Weers, John Bell, Hak-Kim Chan, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 16, 2013
In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisationHui Xin Ong, Faiza Benaouda, Daniela Traini, et al.
Analytical Chemistry|June 20, 2020
Nanoscale Probing of Liposome Encapsulating Drug Nanocrystal Using Atomic Force Microscopy-Infrared SpectroscopyDipesh Khanal, Isra Khatib, Juanfang Ruan, et al.
Pharmaceutical Research|February 9, 2018
Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm InfectionChing-Yee Loo, Wing-Hin Lee, Gianluca Lauretani, et al.
The European Respiratory Journal|June 20, 2020
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studiesJames D Chalmers, David Cipolla, Bruce Thompson, et al.
Thorax|May 18, 2013
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trialDavid J Serisier, Diana Bilton, Anthony De Soyza, et al.
Pulmonary Pharmacology & Therapeutics|December 21, 2020
Treprostinil palmitil, an inhaled long-acting pulmonary vasodilator, does not show tachyphylaxis with daily dosing in ratsRichard W Chapman, Zhili Li, Donald Chun, et al.
European Journal of Pharmacology|September 11, 2021
Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertensionMichel R Corboz, Adam J Plaunt, Vladimir Malinin, et al.
Pageof 6